Similar articles

• Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.

  Umair M, Ikram A, Salman M, Alam MM, Badar N, Rehman Z, Tamim S, Khurshid A, Ahad A, Ahmad H, Ullah S. Umair M, et al. J Med Virol. 2021 May;93(5):2623-2625. doi: 10.1002/jmv.26869. Epub 2021 Feb 19. J Med Virol. 2021. PMID: 33570181 Free PMC article. No abstract available.
• Questions concerning the proximal origin of SARS-CoV-2.

  Seyran M, Pizzol D, Adadi P, El-Aziz TMA, Hassan SS, Soares A, Kandimalla R, Lundstrom K, Tambuwala M, Aljabali AAA, Lal A, Azad GK, Choudhury PP, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Seyran M, et al. J Med Virol. 2021 Mar;93(3):1204-1206. doi: 10.1002/jmv.26478. Epub 2020 Dec 30. J Med Virol. 2021. PMID: 32880995 Free PMC article. No abstract available.
• A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2.

  Das JK, Roy S. Das JK, et al. Genome. 2021 Jul;64(7):665-678. doi: 10.1139/gen-2020-0157. Epub 2021 Mar 31. Genome. 2021. PMID: 33788636
• Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology.

  Kannan S, Shaik Syed Ali P, Sheeza A. Kannan S, et al. Eur Rev Med Pharmacol Sci. 2021 Jun;25(12):4405-4412. doi: 10.26355/eurrev_202106_26151. Eur Rev Med Pharmacol Sci. 2021. PMID: 34227076 Review.
• SARS-CoV-2: phylogenetic status, mutations and therapeutic research based on spike protein.

  Zhu Y. Zhu Y. Eur Rev Med Pharmacol Sci. 2021 Sep;25(18):5843-5852. doi: 10.26355/eurrev_202109_26803. Eur Rev Med Pharmacol Sci. 2021. PMID: 34604976 Review.